Myra A. Nimmo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Myra A. Nimmo has a total of 223 co-authors. Here are the top co-authors by number of shared publications:
- Giuseppe De Vito
Neuromuscular Physiology Laboratory Department of Biomedical Sciences University of Padova Padova Italy
9 shared publications - Melanie Jane Davies
NIHR Leicester Biomedical Research Centre Leicester UK
6 shared publications - Alfred Iing Yoong Tok
School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore, SINGAPORE
5 shared publications - James A. King
National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences Loughborough University Loughborough UK
5 shared publications - Kamlesh Khunti
Diabetes Research Centre, College of Life Sciences University of Leicester Leicester UK
5 shared publications - Steve H. Faulkner
Department of Engineering, SPEED Laboratory, School of Science and Technology Nottingham Trent University Nottingham UK
5 shared publications
Latest Publications
- Open Access
- 1 November 2021
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 46 (11) , 1345-1353
Lower volume throughout the taper and higher intensity in the last interval session prior to a 1500 m time trial improves performance
Eight highly trained middle-distance runners (1500 m personal best 4:01.4 ± 0:09.2 min) completed two 7-day tapers, separated by at least 3 weeks of regular training: (i) prescribed using prediction models from elite middle-distance runners, where continuous running volume was reduced by 30% and interval intensity was equal to 1500 m race pace (RP); and (ii) continuous running volume was reduced by 60% and intensity of the final interval session was completed at 110% of 1500 m race pace (HI). Performance was assessed using 1500 m time trials on an indoor 200 m track 1 day before, and 1 day after each taper. Performance time was improved after HI by 5.2 ± 3.7 s (mean ± 90% confidence limits, p = 0.03) and by 3.2 ± 3.8 s after RP (p = 0.15). The first and second 300 m segments of the 1500 m time trial were faster post-taper in RP (p = 0.012 and p = 0.017, respectively) and HI (both p = 0.012). Running faster than race pace late in a low-volume taper is recommended to improve 1500 m track performance. A positive pacing strategy is adopted after tapering, although care should be taken to avoid an over-fast start. Novelty: A large reduction in volume during tapering and an increase in final interval session intensity improves running performance. Athletes adopt a negative pacing strategy before tapering and a positive-pacing strategy after tapering.
- 1 November 2021
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 46 (11) , 1345-1353
Open AccessLower volume throughout the taper and higher intensity in the last interval session prior to a 1500 m time trial improves performance
Eight highly trained middle-distance runners (1500 m personal best 4:01.4 ± 0:09.2 min) completed two 7-day tapers, separated by at least 3 weeks of regular training: (i) prescribed using prediction models from elite middle-distance runners, where continuous running volume was reduced by 30% and interval intensity was equal to 1500 m race pace (RP); and (ii) continuous running volume was reduced by 60% and intensity of the final interval session was completed at 110% of 1500 m race pace (HI). Performance was assessed using 1500 m time trials on an indoor 200 m track 1 day before, and 1 day after each taper. Performance time was improved after HI by 5.2 ± 3.7 s (mean ± 90% confidence limits, p = 0.03) and by 3.2 ± 3.8 s after RP (p = 0.15). The first and second 300 m segments of the 1500 m time trial were faster post-taper in RP (p = 0.012 and p = 0.017, respectively) and HI (both p = 0.012). Running faster than race pace late in a low-volume taper is recommended to improve 1500 m track performance. A positive pacing strategy is adopted after tapering, although care should be taken to avoid an over-fast start. Novelty: A large reduction in volume during tapering and an increase in final interval session intensity improves running performance. Athletes adopt a negative pacing strategy before tapering and a positive-pacing strategy after tapering.
- Open Access
- 1 March 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 141, 23-31
Appetite-regulatory hormone responses on the day following a prolonged bout of moderate-intensity exercise
- 1 March 2015
- Published by Elsevier in Physiology & Behavior
- Vol. 141, 23-31
Open AccessAppetite-regulatory hormone responses on the day following a prolonged bout of moderate-intensity exercise
- 16 October 2014
- Vol. 28 (3) , 407-17
Dynamic changes in dna methylation status in peripheral blood Mononuclear cells following an acute bout of exercise: Potential impact of exercise-induced elevations in interleukin-6 concentration.
The aim of the present study was to examine the relationship between interleukin (IL)-6 concentrations and DNA methylation in the peripheral blood mononuclear cells (PBMCs) of trained runners after a bout of prolonged, strenuous exercise. Eight healthy trained males completed a treadmill run at 60% vVO(2max) for 120 min followed by a 5-km time trial in a fasted condition. Whole blood samples were taken prior to, immediately before and 24 h following exercise. From these samples, PBMCs were isolated for analysis and plasma IL-6 concentrations were measured. The methylation status of DNA extracted from PBMCs was analysed using the Illumina 27k methylation beadchip platform. Global DNA methylation status was unaltered immediately and up to 24 hours following a bout of prolonged exercise in comparison to pre-exercise. Despite no change in global DNA methylation, plasma IL-6 concentrations were significantly related to the DNA methylation status of 11 genes. Our study demonstrates that the methylome is stable, while discovering a novel link between exercise-induced increases in circulating IL-6 and the DNA methylation status of 11 individual genes. Based on our preliminary findings, the mechanisms by which changes in plasma IL-6 concentrations and DNA methylation in response to exercise interact require further study.
- 16 October 2014
- Vol. 28 (3) , 407-17
Dynamic changes in dna methylation status in peripheral blood Mononuclear cells following an acute bout of exercise: Potential impact of exercise-induced elevations in interleukin-6 concentration.
The aim of the present study was to examine the relationship between interleukin (IL)-6 concentrations and DNA methylation in the peripheral blood mononuclear cells (PBMCs) of trained runners after a bout of prolonged, strenuous exercise. Eight healthy trained males completed a treadmill run at 60% vVO(2max) for 120 min followed by a 5-km time trial in a fasted condition. Whole blood samples were taken prior to, immediately before and 24 h following exercise. From these samples, PBMCs were isolated for analysis and plasma IL-6 concentrations were measured. The methylation status of DNA extracted from PBMCs was analysed using the Illumina 27k methylation beadchip platform. Global DNA methylation status was unaltered immediately and up to 24 hours following a bout of prolonged exercise in comparison to pre-exercise. Despite no change in global DNA methylation, plasma IL-6 concentrations were significantly related to the DNA methylation status of 11 genes. Our study demonstrates that the methylome is stable, while discovering a novel link between exercise-induced increases in circulating IL-6 and the DNA methylation status of 11 individual genes. Based on our preliminary findings, the mechanisms by which changes in plasma IL-6 concentrations and DNA methylation in response to exercise interact require further study.
- 31 July 2014
- Published by IOP Publishing in Chinese Physics B
- Vol. 23 (8) , 088104
Complete coverage of reduced graphene oxide on silicon dioxide substrates
Reduced graphene oxide (RGO) has the advantage of an aqueous and industrial-scale production route. No other approaches can rival the RGO field effect transistor platform in terms of cost (<US$1) and portability (millimetre scale). However the large deviations in the electrical resistivity of this fabricated material prevent it from being used widely. After an ethanol chemical vapor deposition (CVD) post-treatment to graphene oxide with ethanol, carbon islets are deposited preferentially at the edges of existing flakes. With a 2-h treatment, the standard deviation in electrical resistance of the treated chips can be reduced by 99.95%. Thus this process could enable RGO to be used in practical electronic devices.
- 31 July 2014
- Published by IOP Publishing in Chinese Physics B
- Vol. 23 (8) , 088104
Complete coverage of reduced graphene oxide on silicon dioxide substrates
Reduced graphene oxide (RGO) has the advantage of an aqueous and industrial-scale production route. No other approaches can rival the RGO field effect transistor platform in terms of cost (<US$1) and portability (millimetre scale). However the large deviations in the electrical resistivity of this fabricated material prevent it from being used widely. After an ethanol chemical vapor deposition (CVD) post-treatment to graphene oxide with ethanol, carbon islets are deposited preferentially at the edges of existing flakes. With a 2-h treatment, the standard deviation in electrical resistance of the treated chips can be reduced by 99.95%. Thus this process could enable RGO to be used in practical electronic devices.
- 26 June 2014
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 15 (11) , 1263-1269
Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms
Aims To assess the cardiac, vascular, anthropometric, and biochemical determinants of subclinical diastolic dysfunction in younger adults with Type 2 diabetes mellitus (T2DM) using multiparametric contrast-enhanced cardiovascular magnetic resonance (CMR) imaging. Methods and results Twenty adults <40 years with T2DM [mean age 31.8(6.6) years, T2DM duration 4.7(4.0) years] and 20 age and sex-matched controls [10 obese non-diabetic controls and 10 lean controls (LC)] were studied. Cardiac volumes and function, circumferential strain and peak early diastolic strain rate (PEDSR), myocardial perfusion reserve, aortic stiffness (distensibility, pulse-wave velocity), focal fibrosis on late gadolinium enhancement, and pre- and post-contrast T1 mapping for contrast agent partition coefficient (subset, n = 26) were determined by CMR. In the T2DM cohort, mean aortic distensibility correlated with PEDSR ( r = 0.564, P = 0.023) and diabetes duration correlated inversely with PEDSR ( r = −0.534, P = 0.015) on univariate analysis. There was a close association between PEDSR and peak systolic strain ( r = −0.580, P = 0.007). Conclusion In young adults with T2DM, diabetes duration and aortic distensibility were associated with diastolic dysfunction. Interventional studies are required to assess whether cardiac dysfunction can be reversed in this phenotype of patients.
- 26 June 2014
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 15 (11) , 1263-1269
Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms
Aims To assess the cardiac, vascular, anthropometric, and biochemical determinants of subclinical diastolic dysfunction in younger adults with Type 2 diabetes mellitus (T2DM) using multiparametric contrast-enhanced cardiovascular magnetic resonance (CMR) imaging. Methods and results Twenty adults <40 years with T2DM [mean age 31.8(6.6) years, T2DM duration 4.7(4.0) years] and 20 age and sex-matched controls [10 obese non-diabetic controls and 10 lean controls (LC)] were studied. Cardiac volumes and function, circumferential strain and peak early diastolic strain rate (PEDSR), myocardial perfusion reserve, aortic stiffness (distensibility, pulse-wave velocity), focal fibrosis on late gadolinium enhancement, and pre- and post-contrast T1 mapping for contrast agent partition coefficient (subset, n = 26) were determined by CMR. In the T2DM cohort, mean aortic distensibility correlated with PEDSR ( r = 0.564, P = 0.023) and diabetes duration correlated inversely with PEDSR ( r = −0.534, P = 0.015) on univariate analysis. There was a close association between PEDSR and peak systolic strain ( r = −0.580, P = 0.007). Conclusion In young adults with T2DM, diabetes duration and aortic distensibility were associated with diastolic dysfunction. Interventional studies are required to assess whether cardiac dysfunction can be reversed in this phenotype of patients.
- Open Access
- 27 April 2014
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 16 (10) , 931-936
Interleukin‐6 in combination with the interleukin‐6 receptor stimulates glucose uptake in resting human skeletal muscle independently of insulin action
Aim: To examine if the physiological concentrations of both interleukin‐6 ( IL ‐6), in combination with IL‐6 receptor ( IL‐6R ), are able to stimulate glucose uptake in human skeletal muscle and to identify the associated signalling pathways. Methods: Skeletal muscle tissue (˜60 mg) obtained from healthy female volunteers via muscle biopsy was subjected to incubation in the absence or presence of insulin (60 µU /ml), recombinant human IL‐6 (rhIL‐6) (4 ng/ml) or a combination of rhIL ‐6 (4 ng/ml) and rhIL‐6R (100 ng/ml) for 30 min, with glucose transport measured for each incubation. Western blot analysis was conducted on key signalling proteins, protein kinase B ( PKB /Akt), adenosine monophosphate kinase ( AMPK ) and mammalian target of rapamycin ( mTOR ) to gain an early insight into any differing transport mechanisms. Results: Human skeletal muscle exhibited increased glucose uptake with insulin (1.85‐fold; p < 0.05) and stimulated phosphorylation of PKB /Akt and AMPK (0.98 ± 0.23 and 1.49 ± 0.13, respectively, phosphorylated: total; p < 0.05). IL ‐6/ IL‐6R increased phosphorylation of mTOR (fourfold, p < 0.05) compared to insulin, IL ‐6 alone and basal control. IL ‐6 did not stimulate glucose uptake but combined with IL‐6R , induced 1.5‐fold increase in glucose uptake (p < 0.05) and phosphorylation of AMPK (0.95 ± 0.19; phosphorylated: total, p < 0.05). Conclusions: IL ‐6 in combination with IL‐6R and not IL ‐6 alone increased glucose uptake in human skeletal muscle. IL ‐6/ IL‐6R ‐mediated glucose uptake occurred independently of PKB /Akt phosphorylation, showing that IL ‐6/ IL‐6R ‐induced glucose uptake is dependent on a divergent pathway.
- 27 April 2014
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 16 (10) , 931-936
Open AccessInterleukin‐6 in combination with the interleukin‐6 receptor stimulates glucose uptake in resting human skeletal muscle independently of insulin action
Aim: To examine if the physiological concentrations of both interleukin‐6 ( IL ‐6), in combination with IL‐6 receptor ( IL‐6R ), are able to stimulate glucose uptake in human skeletal muscle and to identify the associated signalling pathways. Methods: Skeletal muscle tissue (˜60 mg) obtained from healthy female volunteers via muscle biopsy was subjected to incubation in the absence or presence of insulin (60 µU /ml), recombinant human IL‐6 (rhIL‐6) (4 ng/ml) or a combination of rhIL ‐6 (4 ng/ml) and rhIL‐6R (100 ng/ml) for 30 min, with glucose transport measured for each incubation. Western blot analysis was conducted on key signalling proteins, protein kinase B ( PKB /Akt), adenosine monophosphate kinase ( AMPK ) and mammalian target of rapamycin ( mTOR ) to gain an early insight into any differing transport mechanisms. Results: Human skeletal muscle exhibited increased glucose uptake with insulin (1.85‐fold; p < 0.05) and stimulated phosphorylation of PKB /Akt and AMPK (0.98 ± 0.23 and 1.49 ± 0.13, respectively, phosphorylated: total; p < 0.05). IL ‐6/ IL‐6R increased phosphorylation of mTOR (fourfold, p < 0.05) compared to insulin, IL ‐6 alone and basal control. IL ‐6 did not stimulate glucose uptake but combined with IL‐6R , induced 1.5‐fold increase in glucose uptake (p < 0.05) and phosphorylation of AMPK (0.95 ± 0.19; phosphorylated: total, p < 0.05). Conclusions: IL ‐6 in combination with IL‐6R and not IL ‐6 alone increased glucose uptake in human skeletal muscle. IL ‐6/ IL‐6R ‐mediated glucose uptake occurred independently of PKB /Akt phosphorylation, showing that IL ‐6/ IL‐6R ‐induced glucose uptake is dependent on a divergent pathway.
- 8 March 2014
- Published by Wiley in Diabetic Medicine
- Vol. 31 (7) , 794-798
Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction
Aim: A pilot study to phenotype young adults (< 40 years) with Type 2 diabetes mellitus.Methods: Twenty people with Type 2 diabetes (aged 18–40 years), 10 lean and 10 obese control subjects underwent detailed assessment, including tagged cardiac magnetic resonance imaging, inflammatory proteins, lipids, vitamin D and maximal oxygen uptake. Outcomes were compared between the group with Type 2 diabetes and the control group.Results: Mean (standard deviation) age, Type 2 diabetes duration and BMI in the group with Type 2 diabetes were 31.8 (6.6) years, 4.7 (4.0) years and 33.9 (5.8) kg/m2 respectively. Compared with lean control subjects, those with Type 2 diabetes had more deleterious profiles of hyperlipidaemia, vitamin D deficiency, inflammation and maximal oxygen uptake relative to body mass. However, there was no difference between the group with Type 2 diabetes and the obese control group. The group with Type 2 diabetes had a higher left ventricular mass and a trend towards concentric remodelling compared with the lean control group (P = 0.002, P = 0.052) but not the obese control group (P > 0.05). Peak early diastolic strain rate was reduced in the group with Type 2 diabetes [1.51 (0.24)/s] compared with the lean control [1.97 (0.34)/s, P = 0.001] and obese control [1.78 (0.39)/s, P = 0.042] group.Conclusions: Young adults with Type 2 diabetes and those with obesity have similar adverse cardiovascular risk profiles, higher left ventricular mass and a trend towards left ventricular concentric remodelling. In addition, those with Type 2 diabetes demonstrate diastolic dysfunction, a known risk marker for future heart failure and mortality.
- 8 March 2014
- Published by Wiley in Diabetic Medicine
- Vol. 31 (7) , 794-798
Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction
Aim: A pilot study to phenotype young adults (< 40 years) with Type 2 diabetes mellitus.Methods: Twenty people with Type 2 diabetes (aged 18–40 years), 10 lean and 10 obese control subjects underwent detailed assessment, including tagged cardiac magnetic resonance imaging, inflammatory proteins, lipids, vitamin D and maximal oxygen uptake. Outcomes were compared between the group with Type 2 diabetes and the control group.Results: Mean (standard deviation) age, Type 2 diabetes duration and BMI in the group with Type 2 diabetes were 31.8 (6.6) years, 4.7 (4.0) years and 33.9 (5.8) kg/m2 respectively. Compared with lean control subjects, those with Type 2 diabetes had more deleterious profiles of hyperlipidaemia, vitamin D deficiency, inflammation and maximal oxygen uptake relative to body mass. However, there was no difference between the group with Type 2 diabetes and the obese control group. The group with Type 2 diabetes had a higher left ventricular mass and a trend towards concentric remodelling compared with the lean control group (P = 0.002, P = 0.052) but not the obese control group (P > 0.05). Peak early diastolic strain rate was reduced in the group with Type 2 diabetes [1.51 (0.24)/s] compared with the lean control [1.97 (0.34)/s, P = 0.001] and obese control [1.78 (0.39)/s, P = 0.042] group.Conclusions: Young adults with Type 2 diabetes and those with obesity have similar adverse cardiovascular risk profiles, higher left ventricular mass and a trend towards left ventricular concentric remodelling. In addition, those with Type 2 diabetes demonstrate diastolic dysfunction, a known risk marker for future heart failure and mortality.
- Open Access
- 1 March 2014
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 114 (6) , 1207-1216
The detection and measurement of interleukin-6 in venous and capillary blood samples, and in sweat collected at rest and during exercise
This study aimed to quantify the relationship between venous and capillary blood sampling methods for the measurement of plasma interleukin-6 (IL-6). A parallel study was conducted to determine the possibility of measuring IL-6 in sweat using an enzyme-linked immunosorbent assay (ELISA) and investigate the relationship between plasma- and sweat-derived measures of IL-6. Twelve male participants were recruited for the measurement of IL-6 at rest and during exercise (study 1). An additional group of five female participants was recruited for the measurement of IL-6 in venous blood versus sweat at rest and following exercise (study 2). In study 1, venous and capillary blood samples were collected at rest and in response to exercise. In study 2, venous and sweat samples were collected following exercise. Mean plasma IL-6 concentration was not different between venous and capillary blood sampling methods either at rest (4.27 ± 5.40 vs. 4.14 ± 4.45 pg ml−1), during (5.40 ± 5.17 vs. 5.58 ± 6.34 pg ml−1), or in response to exercise (6.95 ± 6.37 vs. 6.99 ± 6.74 pg ml−1). There was no IL-6 detectable in sweat either at rest or following exercise. There are no differences in the measurement of plasma IL-6 using either venous or capillary blood sampling methods. Capillary measurement represents a minimally invasive way of measuring IL-6 and detecting changes in IL-6, which are linked to fatigue and overtraining.
- 1 March 2014
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 114 (6) , 1207-1216
Open AccessThe detection and measurement of interleukin-6 in venous and capillary blood samples, and in sweat collected at rest and during exercise
This study aimed to quantify the relationship between venous and capillary blood sampling methods for the measurement of plasma interleukin-6 (IL-6). A parallel study was conducted to determine the possibility of measuring IL-6 in sweat using an enzyme-linked immunosorbent assay (ELISA) and investigate the relationship between plasma- and sweat-derived measures of IL-6. Twelve male participants were recruited for the measurement of IL-6 at rest and during exercise (study 1). An additional group of five female participants was recruited for the measurement of IL-6 in venous blood versus sweat at rest and following exercise (study 2). In study 1, venous and capillary blood samples were collected at rest and in response to exercise. In study 2, venous and sweat samples were collected following exercise. Mean plasma IL-6 concentration was not different between venous and capillary blood sampling methods either at rest (4.27 ± 5.40 vs. 4.14 ± 4.45 pg ml−1), during (5.40 ± 5.17 vs. 5.58 ± 6.34 pg ml−1), or in response to exercise (6.95 ± 6.37 vs. 6.99 ± 6.74 pg ml−1). There was no IL-6 detectable in sweat either at rest or following exercise. There are no differences in the measurement of plasma IL-6 using either venous or capillary blood sampling methods. Capillary measurement represents a minimally invasive way of measuring IL-6 and detecting changes in IL-6, which are linked to fatigue and overtraining.
- 22 October 2013
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 2 (1) , 109-114
The mechanism of graphene oxide as a growth template for complete reduced graphene oxide coverage on an SiO2substrate
Reduced Graphene Oxide (rGO) has the distinct advantage of an aqueous and industrial-scalable production route. However large deviation in the electrical resistivity of fabricated rGO devices, caused by inhomogeneous coverage of rGO on the substrate, prevents its practical application in electronic devices. This critical problem could be solved by using an ethanol chemical vapour deposition (CVD) treatment on graphene oxide (GO). With the treatment, not only GO is reduced to rGO, but also rGO preferentially grows outwards from the edges of the existing GO template and enlarge in size until rGO completely covers the substrate. The growth sequence is presented and our results indicate that the growth supports the free radical condensate growth mechanism. After the ethanol CVD treatment, the standard deviation in electrical resistivity decreased significantly by 99.95% (1.60 × 106 to 7.72 × 102 Ω per square) in comparison with hydrazine-reduced rGO substrates. As no carbon signatures on the substrate were observed when no template was used, this work indicates that GO could act as a template for subsequent formation of rGO.
- 22 October 2013
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 2 (1) , 109-114
The mechanism of graphene oxide as a growth template for complete reduced graphene oxide coverage on an SiO2substrate
Reduced Graphene Oxide (rGO) has the distinct advantage of an aqueous and industrial-scalable production route. However large deviation in the electrical resistivity of fabricated rGO devices, caused by inhomogeneous coverage of rGO on the substrate, prevents its practical application in electronic devices. This critical problem could be solved by using an ethanol chemical vapour deposition (CVD) treatment on graphene oxide (GO). With the treatment, not only GO is reduced to rGO, but also rGO preferentially grows outwards from the edges of the existing GO template and enlarge in size until rGO completely covers the substrate. The growth sequence is presented and our results indicate that the growth supports the free radical condensate growth mechanism. After the ethanol CVD treatment, the standard deviation in electrical resistivity decreased significantly by 99.95% (1.60 × 106 to 7.72 × 102 Ω per square) in comparison with hydrazine-reduced rGO substrates. As no carbon signatures on the substrate were observed when no template was used, this work indicates that GO could act as a template for subsequent formation of rGO.
- Open Access
- 6 October 2013
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 113 (12) , 3039-3047
The impact of high-intensity intermittent exercise on resting metabolic rate in healthy males
Introduction High-intensity intermittent exercise training (HIT) may favourably alter body composition despite low training volumes and predicted energy expenditure (EE). Purpose To characterise the acute impact of two common HIT protocols on EE and post-exercise oxygen consumption (11 h EPOC). Methods Oxygen consumption (l min−1), respiratory exchange ratio (RER) and EE were measured in nine healthy, lean males over 12 h under three conditions: control (CON), HIT1 (10 × 1 min high-intensity cycling bouts followed by 1 min rest) and HIT2 (10 × 4 min high-intensity cycling bouts followed by 2 min rest). Results Total exercise period EE during HIT1 (1,151 ± 205 kJ) (mean ± SD) was significantly lower than HIT2 (2,788 ± 322 kJ; p < 0.001). EE within the 60 min after exercise was significantly albeit marginally higher after HIT1 (388 ± 44 kJ; p = 0.02) and HIT2 (389 ± 39 kJ; p = 0.01) compared with CON (329 ± 39 kJ), with no difference between exercise conditions (p = 0.778). RER during this period was significantly lower in HIT1 (0.78 ± 0.06; p = 0.011) and HIT2 (0.76 ± 0.04; p = 0.004) compared with CON (0.87 ± 0.06). During the ‘slow phase’ of EPOC (1.25–9.75 h), there were no significant differences in EE (p = 0.07) or RER (p = 0.173) between trials. Conclusions Single HIT sessions notably increases EE during exertion; however, the influence on metabolic rate post-exercise is transient and relatively minor.
- 6 October 2013
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 113 (12) , 3039-3047
Open AccessThe impact of high-intensity intermittent exercise on resting metabolic rate in healthy males
Introduction High-intensity intermittent exercise training (HIT) may favourably alter body composition despite low training volumes and predicted energy expenditure (EE). Purpose To characterise the acute impact of two common HIT protocols on EE and post-exercise oxygen consumption (11 h EPOC). Methods Oxygen consumption (l min−1), respiratory exchange ratio (RER) and EE were measured in nine healthy, lean males over 12 h under three conditions: control (CON), HIT1 (10 × 1 min high-intensity cycling bouts followed by 1 min rest) and HIT2 (10 × 4 min high-intensity cycling bouts followed by 2 min rest). Results Total exercise period EE during HIT1 (1,151 ± 205 kJ) (mean ± SD) was significantly lower than HIT2 (2,788 ± 322 kJ; p < 0.001). EE within the 60 min after exercise was significantly albeit marginally higher after HIT1 (388 ± 44 kJ; p = 0.02) and HIT2 (389 ± 39 kJ; p = 0.01) compared with CON (329 ± 39 kJ), with no difference between exercise conditions (p = 0.778). RER during this period was significantly lower in HIT1 (0.78 ± 0.06; p = 0.011) and HIT2 (0.76 ± 0.04; p = 0.004) compared with CON (0.87 ± 0.06). During the ‘slow phase’ of EPOC (1.25–9.75 h), there were no significant differences in EE (p = 0.07) or RER (p = 0.173) between trials. Conclusions Single HIT sessions notably increases EE during exertion; however, the influence on metabolic rate post-exercise is transient and relatively minor.